Study pinpoints key protein in a severe vascular disease

Study pinpoints key protein in a severe vascular disease
Fate mapping indicates that pre–existing smooth muscle cells contribute to the excess aortic smooth muscle in elastin mutants.

The aorta, the body's largest artery, is like a hose through which our blood flows. When the hose is squeezed, the pump (i.e., the heart) is forced to work harder. In a new study, Yale researchers investigated factors that squeeze, or narrow, the aorta in a common vascular disease, revealing a target for potential new treatments.

Individuals who suffer from supravalvular , a condition characterized by narrowing of the , have only one copy instead of the usual two copies of the gene encoding elastin. Elastin is critical because it allows the artery to expand and contract as blood is pumped through it. To better understand this , the research team analyzed tissue from patients as well as mice with the . In both cases, the researchers observed an increase in a protein known as integrin beta3. When the scientists inhibited integrin beta3 genetically or with a drug that blocks its activity, the aortic stenosis was mitigated.

"The most important findings were that when we inhibit integrin beta3 in mice lacking the elastin gene, it prevents the stenosis and increases their survival," said senior author Daniel Greif, assistant professor of cardiology and the study's senior author. First author Ashish Misra, a postdoctoral fellow in the Greif lab, emphasized that this increased survival is unprecedented in mice that lack elastin.

The study results promise to lead to medical therapies that would replace or at least delay major surgery or other invasive treatments, which are the only current options for patients, say the investigators.

The study was published online Feb. 8 in the Journal of Experimental Medicine.

More information: Ashish Misra et al. Integrin β3 inhibition is a therapeutic strategy for supravalvular aortic stenosis, The Journal of Experimental Medicine (2016). DOI: 10.1084/jem.20150688

Journal information: Journal of Experimental Medicine
Provided by Yale University
Citation: Study pinpoints key protein in a severe vascular disease (2016, February 9) retrieved 29 March 2024 from https://medicalxpress.com/news/2016-02-key-protein-severe-vascular-disease.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Scientists make advance in cancer research

2 shares

Feedback to editors